Role of Low Dose Injectable Progesterone in Triggering Ovulation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorThe General Authority for Teaching Hospitals and Institutes
The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.
Age from 20 to 35 years.
Infertile women.
Basal follicle-stimulating hormone (FSH) level <10 mIU/ml.
Poor ovarian reserve.
Immunological disease.
Endometriosis.
Uterine abnormality.